(2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide

C28H36N4O3 — CID 166040529

IUPAC(2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide
SMILESCC(C)(C)c1ccc(N(C(=O)[C@H]2CC(=O)CN2)C(C(=O)NC2CCCCC2)c2cccnc2)cc1
InChIInChI=1S/C28H36N4O3/c1-28(2,3)20-11-13-22(14-12-20)32(27(35)24-16-23(33)18-30-24)25(19-8-7-15-29-17-19)26(34)31-21-9-5-4-6-10-21/h7-8,11-15,17,21,24-25,30H,4-6,9-10,16,18H2,1-3H3,(H,31,34)/t24-,25?/m1/s1
InChIKeyUZAKPCZUZOCUAI-IKOFQBKESA-N
MW476.62 g/mol
LogP3.83
Rot. Bonds6

About (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide

(2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide (PubChem CID 166040529) has the molecular formula C28H36N4O3 and a molecular weight of 476.62 g/mol. Its IUPAC name is (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide
PubChem CID166040529
Molecular FormulaC28H36N4O3
Molecular Weight476.62 g/mol
Exact Mass476.28
IUPAC Name(2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide
SMILESCC(C)(C)c1ccc(N(C(=O)[C@H]2CC(=O)CN2)C(C(=O)NC2CCCCC2)c2cccnc2)cc1
InChIInChI=1S/C28H36N4O3/c1-28(2,3)20-11-13-22(14-12-20)32(27(35)24-16-23(33)18-30-24)25(19-8-7-15-29-17-19)26(34)31-21-9-5-4-6-10-21/h7-8,11-15,17,21,24-25,30H,4-6,9-10,16,18H2,1-3H3,(H,31,34)/t24-,25?/m1/s1
InChIKeyUZAKPCZUZOCUAI-IKOFQBKESA-N
XLogP3.83
TPSA91.40 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500476.62
LogP ≤ 53.83
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide?
The IUPAC name of (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide (CID 166040529) is (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide.
What is the SMILES notation for (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide?
The canonical SMILES for (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide is CC(C)(C)c1ccc(N(C(=O)[C@H]2CC(=O)CN2)C(C(=O)NC2CCCCC2)c2cccnc2)cc1.
What is the InChIKey of (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide?
The InChIKey is UZAKPCZUZOCUAI-IKOFQBKESA-N. The full InChI is InChI=1S/C28H36N4O3/c1-28(2,3)20-11-13-22(14-12-20)32(27(35)24-16-23(33)18-30-24)25(19-8-7-15-29-17-19)26(34)31-21-9-5-4-6-10-21/h7-8,11-15,17,21,24-25,30H,4-6,9-10,16,18H2,1-3H3,(H,31,34)/t24-,25?/m1/s1.
What are the key properties of (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide?
(2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide has a molecular weight of 476.62 g/mol, XLogP of 3.83, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-(4-tert-butylphenyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-4-oxopyrrolidine-2-carboxamide is sourced from PubChem (CID 166040529), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).